Controlling the expression of a specific group of oncogenic and tumor-suppressive transcription factors might lead to selective death of cancer cells, because healthy cells are able to tolerate the loss of TF function with slight consequences, due to the presence of proteins in the transcriptional regulatory network that are capable of supplying the missing function in normal signaling pathways [179]. The gene discussed is TF; the disease is neoplasm.